| GRSRX | RRGIX | GRSRX / RRGIX | |
| Total Expense Ratio | 1.34 | 0.95 | 141% |
| Annual Report Gross Expense Ratio | 1.34 | 1.03 | 130% |
| Fund Existence | 11 years | 20 years | - |
| Gain YTD | 3.472 | 4.189 | 83% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.05B | 166M | 1,233% |
| Annual Yield % from dividends | 2.81 | 2.57 | 109% |
| Returns for 1 year | 12.16 | 11.88 | 102% |
| Returns for 3 years | 13.95 | 17.81 | 78% |
| Returns for 5 years | 16.79 | 12.07 | 139% |
| Returns for 10 years | 57.51 | 36.21 | 159% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VKSIX | 20.18 | 0.46 | +2.33% |
| Virtus KAR Small-Mid Cap Core I | |||
| CGLAX | 17.95 | 0.06 | +0.34% |
| Calvert Global Equity Fund Class A | |||
| KTRSX | 9.41 | -0.03 | -0.32% |
| DWS Global Income Builder S | |||
| OEGYX | 34.05 | -0.68 | -1.96% |
| Invesco Discovery Mid Cap Growth Y | |||
| BIPSX | 36.08 | -1.04 | -2.80% |
| ProFunds Biotechnology UltraSector Svc | |||